EUVIMEDEUVIMED entdecken
Crossref

The Study of Genetic Mutations in Genes AGPAT2, LMNA, PPARG, PLIN1, AKT2, CIDEC in Köbberling–Dunnigan Syndrome

International Journal of Diabetes & Metabolic Disorders · 2019

DOI: 10.33140/ijdmd.04.02.01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Diabetes & Metabolic Disorders, 2019. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Köbberling-Dunnigan syndrome, also known as partial familial lip dystrophy, is a rare genetic disorder characterized by abnormal distribution of adipose tissue. Many people with Köbberling-Dunnigan syndrome develop insulin resistance, a condition in which body tissues cannot adequately respond to insulin hormone. Insulin hormone is a hormone that helps regulate the level of your blood glucose. Köbberling-Dunnigan syndrome can be due to mutations in several different genes. However, type 2 Köbberling-Dunnigan syndrome is caused by the mutation of the LMNA gene, which is based on the long arm of chromosome 1 as 1q22.

Zitieren

APA

(2019). The Study of Genetic Mutations in Genes AGPAT2, LMNA, PPARG, PLIN1, AKT2, CIDEC in Köbberling–Dunnigan Syndrome. International Journal of Diabetes & Metabolic Disorders. https://doi.org/10.33140/ijdmd.04.02.01

Vancouver

The Study of Genetic Mutations in Genes AGPAT2, LMNA, PPARG, PLIN1, AKT2, CIDEC in Köbberling–Dunnigan Syndrome. International Journal of Diabetes & Metabolic Disorders. 2019. doi:10.33140/ijdmd.04.02.01

BibTeX
@article{euvimed2019,
  title = {The Study of Genetic Mutations in Genes AGPAT2, LMNA, PPARG, PLIN1, AKT2, CIDEC in Köbberling–Dunnigan Syndrome},
  journal = {International Journal of Diabetes & Metabolic Disorders},
  year = {2019},
  doi = {10.33140/ijdmd.04.02.01}
}
Kostenlos starten →